Arthrosurface wins CE Mark approval for Uni knee resurfacing system

With this approval, the company is poised to move into the fast growing European market of partial knee replacements.

Steve Ek, COO of Arthrosurface, said: “We have taken our clinical experiences from the company’s HemiCAP focal knee resurfacing product in Europe, in part, to create a larger sized Unicondylar knee system that is joint preserving while having the fit of a device similar to an off-the-shelf custom implant.”

The company believes that its product lines address a gap in existing treatments, specifically between biological options and joint replacement. The company maintains that biological treatments, such as grafting and cell regeneration, may be viable options for those that are young; alternatively total joint replacement surgery may be effective for those that are much older or less active. The UniCAP system may now provide an option for this previously unaddressed market.